Literature DB >> 33905283

The impact of COVID-19 on palliative care for people with Parkinson's and response to future pandemics.

K Ray Chaudhuri1,2, Katarina Rukavina1,2, Victor McConvey3, Angelo Antonini4, Stefan Lorenzl5,6,7, Roongroj Bhidayasiri8,9, Maria Elisa Pimentel Piemonte10, Shen-Yang Lim11, Edward Richfield12, Richard Walker13, Raquel Bouca-Machado14,15, Sabrina Bajwah16, Wei Gao16, Dhaval Trivedi1,2, Janis Miyasaki17.   

Abstract

Introduction: Although in some countries, palliative care (PC) still remains poorly implemented, its importance throughout the course of Parkinson's disease (PD) is increasingly being acknowledged. With an emergence of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic, growing emphasis has been placed on the palliative needs of people with Parkinson's (PwP), particularly elderly, frail, and with comorbidities.Areas covered: The ongoing COVID-19 pandemic poses an enormous challenge on aspects of daily living in PwP and might interact negatively with a range of motor and non-motor symptoms (NMS), both directly and indirectly - as a consequence of pandemic-related social and health care restrictions. Here, the authors outline some of the motor and NMS relevant to PC, and propose a pragmatic and rapidly deployable, consensus-based PC approach for PwP during the ongoing COVID-19 pandemic, potentially relevant also for future pandemics.Expert opinion: The ongoing COVID-19 pandemic poses a considerable impact on PwP and their caregivers, ranging from mental health issues to worsening of physical symptoms - both in the short- and long-term, (Long-COVID) and calls for specific, personalized PC strategies relevant in a lockdown setting globally. Validated assessment tools should be applied remotely to flag up particular motor or NMS that require special attention, both in short- and long-term.

Entities:  

Keywords:  COVID-19; Parkinson’s disease; non-motor symptoms; palliative care; quality of life

Mesh:

Year:  2021        PMID: 33905283     DOI: 10.1080/14737175.2021.1923480

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  5 in total

1.  Parkinson's disease and Covid-19: The effect and use of telemedicine.

Authors:  Aleksandra M Podlewska; Daniel J van Wamelen
Journal:  Int Rev Neurobiol       Date:  2022-07-14       Impact factor: 4.280

2.  Parkinson's disease and Covid-19: Is there an impact of ethnicity and the need for palliative care.

Authors:  Katarina Rukavina; Victor McConvey; Kallol Ray Chaudhuri; Janis Miyasaki
Journal:  Int Rev Neurobiol       Date:  2022-04-27       Impact factor: 4.280

Review 3.  A Peek into Pandora's Box: COVID-19 and Neurodegeneration.

Authors:  Abhishek Chandra; Ashu Johri
Journal:  Brain Sci       Date:  2022-01-30

4.  Updates on Palliative Medicine in the COVID-19 Era.

Authors:  Giustino Varrassi; Martina Rekatsina
Journal:  J Clin Med       Date:  2022-01-09       Impact factor: 4.241

Review 5.  Moving Forward from the COVID-19 Pandemic: Needed Changes in Movement Disorders Care and Research.

Authors:  B Y Valdovinos; J S Modica; R B Schneider
Journal:  Curr Neurol Neurosci Rep       Date:  2022-02-02       Impact factor: 6.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.